Neuss, Germany
Profil GmbH is a specialized clinical research organization established in 1999 in Germany, focused on diabetes and related metabolic diseases. This focus distinguishes it from other CROs, offering sophisticated experimental methods, including glucose clamp studies and isotope dilution techniques, essential for advancing anti-diabetic compounds.
The company was originally a spin-off from the University of Düsseldorf, embracing its academic roots to maintain high scientific standards. Its infrastructure includes a large recruitment database, a GMP-certified pharmacy, and an in-house clinical unit with over 60 beds—all vital in adhering to strict timelines for trials.
Although Profil has not disclosed any recent investments, its robust infrastructure, ISO certifications, and a strong publication record—with over 360 papers—highlight its respected status in healthcare research. Its focus on integrating regulatory and scientific expertise offers valuable insight for investors interested in cutting-edge research in metabolic diseases.
